Claudia Piccinini
Meldola, 47014, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 14, 2025
Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial.
Journal: Journal of translational medicine
Published: January 28, 2025
Sequencing of Checkpoint or BRAF/MEK Inhibitors on Brain Metastases in Melanoma.
Journal: NEJM evidence
Published: September 24, 2024
Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products.
Journal: Cytotherapy
Published: April 12, 2024
In vitro CAR-T cell killing: validation of the potency assay.
Journal: Cancer immunology, immunotherapy : CII
Published: April 11, 2024
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.
Journal: Nature communications
Published: May 15, 2023
Stability Program in Dendritic Cell Vaccines: A "Real-World" Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center.
Journal: Vaccines
Published: May 13, 2022
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma.
Journal: Frontiers in immunology
Published: September 16, 2021
Potency Assessment of Dendritic Cell Anticancer Vaccine: Validation of the Co-Flow DC Assay.
Journal: International journal of molecular sciences
Published: May 04, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026